Trends in prescription of anti-seizure medications in Japan between 2018 and 2021: A retrospective study using the National Database Open Data Japan
Epilepsy & Behavior · 2024-10 · 159 · 109949
DOI: 10.1016/j.yebeh.2024.109949 ↗Kurz gefasst
Fachartikel in der Zeitschrift Epilepsy & Behavior, 2024-10. Verfasst von Hiroyuki Ura und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacy, Shonan University of Medical Science, Yokohama, Japan; Department of Pharmacy Services, Shiomidai Hospital, Yokohama…. Hauptthemen laut MEDLINE: Anticonvulsants, Databases, Factual. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 49 Literaturangaben.
Abstract (Originalsprache)
PURPOSE: This retrospective study aimed to analyze anti-seizure medication (ASM) prescription trends in Japan, particularly among older adults and women of childbearing age, to inform future treatment strategies and optimize ASM selection criteria. METHODS: Data were extracted from the National Database Open Data Japan for fiscal years (FY) 2018-2021, covering prescriptions across sex and 5-year age groups. We conducted data imputation for prescriptions under 1,000 units to maintain anonymity, calculated the estimated number of patients using standard adult maintenance doses, and adjusted for pediatric dosing using Augsberger's formula. RESULTS: Our analysis revealed a 7.6% increase in ASM usage, with a notable shift from older to newer ASMs, such as levetiracetam (LEV) and lamotrigine (LTG). LEV and LTG prescriptions increased by 26.7% and 15.0% from FY 2018 to FY 2021, respectively, whereas older ASMs such as phenytoin, declined. Sex-specific analysis showed a higher LTG prescription rate among women, especially in adolescent and young adult cohorts, where the female-to-male prescription ratio increased from 1.65 to 1.85. Valproate (VPA) and LEV accounted for 57.0% of ASM prescriptions in older adults. The number of inpatient LTG prescriptions was notably lower than that of outpatient LTG prescriptions across age groups. Pediatric use of generics was lower than that in other age groups. CONCLUSION: This study revealed that newer ASMs are being used increasingly, with a significant proportion of VPA continuously prescribed among women of childbearing age. In older adults, VPA and LEV accounted for more than half of the ASM prescriptions. These findings are crucial for developing future treatment strategies and improving the ASM selection criteria.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Pharmacy, Shonan University of Medical Science, Yokohama, Japan; Department of Pharmacy Services, Shiomidai Hospital, Yokohama, Japan. Electronic address: urahiroyuki@gmail.com.
- Department of Pharmacy Services, Nippon Medical School Musashi Kosugi Hospital, Kawasaki, Japan.
- Department of Clinical Pharmacy, Shonan University of Medical Science, Yokohama, Japan.
Zitieren
APA
Ura, H., Matsuoka, N., Kubota, K., & Sadamoto, K. (2024). Trends in prescription of anti-seizure medications in Japan between 2018 and 2021: A retrospective study using the National Database Open Data Japan. Epilepsy & Behavior, 159, 109949. https://doi.org/10.1016/j.yebeh.2024.109949
Vancouver
Ura H, Matsuoka N, Kubota K, Sadamoto K. Trends in prescription of anti-seizure medications in Japan between 2018 and 2021: A retrospective study using the National Database Open Data Japan. Epilepsy & Behavior. 2024;159:109949. doi:10.1016/j.yebeh.2024.109949
BibTeX
@article{Ura2024,
author = {Ura, Hiroyuki and Matsuoka, Noriko and Kubota, Kiyoshi and Sadamoto, Kiyomi},
title = {Trends in prescription of anti-seizure medications in Japan between 2018 and 2021: A retrospective study using the National Database Open Data Japan},
journal = {Epilepsy & Behavior},
year = {2024},
volume = {159},
pages = {109949},
doi = {10.1016/j.yebeh.2024.109949}
}
EUVIMED